Viridian Therapeutics
Kathryn Hutnick is an experienced Associate Scientist with a strong background in microbiology. Currently serving as Associate Scientist III at miRagen Therapeutics, Inc. since February 2014, Kathryn has advanced through roles at the same company, beginning as Associate Scientist II from 2009 to 2013. Prior to joining miRagen Therapeutics, Kathryn worked as an Associate Scientist at Thermo Fisher Scientific from 2002 to 2008. Kathryn holds a Bachelor of Science degree in Microbiology from Auburn University, obtained in 2000.
Viridian Therapeutics
2 followers
Viridian is dedicated to improving patients’ lives through the discovery and development of RNA-based therapeutics, with a specific focus on microRNAs.